Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Ulla Birgitte Christiansen in
Google Scholar
PubMed
Department of Gynaecology and Obstetrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Anne Sørensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Søren Risom Kristensen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
diagnostic clue for the assessment of thyroid function in this patient came across because unexplained prolonged APTT was identified during the testing for thrombophilia after severe pregnancy complications. Case presentation A 32-year-old woman was
Search for other papers by Paolo Cavarzere in
Google Scholar
PubMed
Search for other papers by Laura Palma in
Google Scholar
PubMed
Search for other papers by Lara Nicolussi Principe in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Monica Vincenzi in
Google Scholar
PubMed
Search for other papers by Silvana Lauriola in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Rossella Gaudino in
Google Scholar
PubMed
Search for other papers by Virginia Murri in
Google Scholar
PubMed
Search for other papers by Luigi Lubrano in
Google Scholar
PubMed
Search for other papers by Giuliana Rossi in
Google Scholar
PubMed
Search for other papers by Alessia Sallemi in
Google Scholar
PubMed
Search for other papers by Ermanna Fattori in
Google Scholar
PubMed
Regional Center for Newborn Screening, Diagnosis and Treatment of Congenital Metabolic and Endocrinological Diseases, Verona, Italy
Search for other papers by Marta Camilot in
Google Scholar
PubMed
Pediatric Section, Department Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Regional Center for the Diagnosis and Treatment of Children and Adolescents Rare Skeletal Disorders, Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy
Search for other papers by Franco Antoniazzi in
Google Scholar
PubMed
Introduction During pregnancy, normal thyroid function is essential to ensure the regular development of the fetus ( 1 , 2 ). Overt or subclinical maternal hypothyroidism can modify, in fact, the course of pregnancy and the development of the
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Kamilla R Riis in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla B Larsen in
Google Scholar
PubMed
Search for other papers by Bjarke R Medici in
Google Scholar
PubMed
Search for other papers by Christian Z Jensen in
Google Scholar
PubMed
Search for other papers by Kristian H Winther in
Google Scholar
PubMed
Search for other papers by Emil L Larsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Data and Data Support, Region Zealand, Sorø, Denmark
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Jeppe L la Cour in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Thomas H Brix in
Google Scholar
PubMed
Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, University Hospital Nordsjælland, Hillerød, Denmark
Search for other papers by Henrik E Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Herlev, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen J Bonnema in
Google Scholar
PubMed
the reference range of 0.3–4.0 mIU/L and total plasma thyroxine (TT4) below the reference range of 60–130 nmol/L) or mild (plasma TSH above the reference range, and plasma TT4 within the reference range). Exclusion criteria were pregnancy or planned
Laboratorio 6, Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados-Instituto Politécnico Nacional, Delegación Tlalpan, Ciudad de México, México
Search for other papers by Jorge Alberto Tapia-Martínez in
Google Scholar
PubMed
Search for other papers by Margarita Franco-Colín in
Google Scholar
PubMed
Search for other papers by Vanessa Blas-Valdivia in
Google Scholar
PubMed
Search for other papers by Edgar Cano-Europa in
Google Scholar
PubMed
neonates, but we believe that it is crucial to have a thyroid state screening before or during pregnancy to avoid erroneous metabolic and thyroid gland programming and the development of cardiometabolic diseases in adulthood. The results presented allow
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Camilla Bøgelund Larsen in
Google Scholar
PubMed
Search for other papers by Kristian Hillert Winther in
Google Scholar
PubMed
Search for other papers by Per Karkov Cramon in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Nils Jakob Knudsen in
Google Scholar
PubMed
QualityMetric Inc, Johnston, Lincoln, Rhode Island, USA
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Search for other papers by Lutz Schomburg in
Google Scholar
PubMed
Search for other papers by Kamil Demircan in
Google Scholar
PubMed
Search for other papers by Thilo Samson Chillon in
Google Scholar
PubMed
Search for other papers by Jeppe Gram in
Google Scholar
PubMed
Search for other papers by Stinus Gadegaard Hansen in
Google Scholar
PubMed
Internal Medicine Research Unit, University Hospital of Southern Jutland, Aabenraa, Denmark
Search for other papers by Frans Brandt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Institute of Clinical Medicine, Faculty of Health and Clinical Sciences, Copenhagen University, Copenhagen, Denmark
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
surgery; antithyroid drug treatment; comorbidity rendering the participant unable to process patient-reported outcomes or receive intervention during the trial; immunomodulatory medication; other medications known to affect thyroid function; pregnancy
Search for other papers by Roberto Fiore in
Google Scholar
PubMed
Search for other papers by Stefano La Rosa in
Google Scholar
PubMed
Search for other papers by Silvia Uccella in
Google Scholar
PubMed
Search for other papers by Deborah Marchiori in
Google Scholar
PubMed
Search for other papers by Peter A Kopp in
Google Scholar
PubMed
gradually during pregnancy, although total expression increases, in order to regulate maternal transfer of thyroid hormone to the fetus. The overexpression of D3 in tumor tissue can lead to hypothyroidism whenever its activity exceeds the maximal synthesis
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Bjarke Røssner Medici in
Google Scholar
PubMed
Search for other papers by Christian Zinck Jensen in
Google Scholar
PubMed
Search for other papers by Anne Ahrendt Bjerregaard in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
-10: DC73.9) ever, and those who redeemed a prescription of antithyroid medication 2 years before redeeming T3 and/or DTE to exclude current block/replace treatment. Further, we chose a grace period with pregnancy or abortion ± 1 year. According to
Search for other papers by Irene Campi in
Google Scholar
PubMed
Search for other papers by Marco Dell’Acqua in
Google Scholar
PubMed
Search for other papers by Elisa Stellaria Grassi in
Google Scholar
PubMed
Search for other papers by Maria Cristina Vigone in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Possible causes of refractory hypothyroidism. Mechanism Associated condition Poor compliance to levothyroxine therapy Unintentional Factitious disorders/malingering Increased thyroxine requirement Pregnancy and weight
Search for other papers by Ladan Mehran in
Google Scholar
PubMed
Search for other papers by Atieh Amouzegar in
Google Scholar
PubMed
Search for other papers by Hengameh Abdi in
Google Scholar
PubMed
Search for other papers by Negar Delbari in
Google Scholar
PubMed
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Search for other papers by Elham Madreseh in
Google Scholar
PubMed
Search for other papers by Maryam Tohidi in
Google Scholar
PubMed
Search for other papers by Mohammad Ali Mansournia in
Google Scholar
PubMed
Search for other papers by Fereidoun Azizi in
Google Scholar
PubMed
iodine ( n = 2), pregnancy ( n = 145), TSH <0.1 and TSH >10 µ/L ( n = 279) as well as those with incomplete laboratory or missing data ( n = 211). Subsequently, 4,905 eligible participants remained to enter the current study (Fig. 1 ) . Fig. 1
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Bronia Arnott in
Google Scholar
PubMed
Search for other papers by Dawn Teare in
Google Scholar
PubMed
Search for other papers by Shaun Hiu in
Google Scholar
PubMed
Search for other papers by Nicki O’Brien in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
, vascular risk, pregnancy status, etc.) should be considered particularly when contemplating treatment [ 19 ]. The results of this survey suggest that most clinicians in our sample are aware of the relevant guidelines that recommend against treatment in